Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
5
50%
Ph phase_1
1
10%
Ph not_applicable
1
10%
Ph phase_3
3
30%

Phase Distribution

1

Early Stage

5

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
5(50.0%)
Phase 3Large-scale testing
3(30.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)
Other(3)

Detailed Status

unknown3
Completed3
Withdrawn2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (10.0%)
Phase 25 (50.0%)
Phase 33 (30.0%)
N/A1 (10.0%)

Trials by Status

recruiting110%
unknown330%
withdrawn220%
completed330%
not_yet_recruiting110%

Recent Activity

1 active trials
Showing 5 of 10
not_yet_recruitingnot_applicable

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

NCT06102252
withdrawnphase_1

Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

NCT04030000
unknownphase_2

Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients

NCT05294900
recruitingphase_3

Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

NCT04137653
withdrawnphase_3

CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

NCT00576225
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06102252Not Applicable

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

Not Yet Recruiting
NCT04030000Phase 1

Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

Withdrawn
NCT05294900Phase 2

Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients

Unknown
NCT04137653Phase 3

Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

Recruiting
NCT00576225Phase 3

CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

Withdrawn
NCT00226915Phase 3

Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

Completed
NCT01196234Phase 2

Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer

Completed
NCT00708812Phase 2

Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer

Completed
NCT01158144Phase 2

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

Unknown
NCT00894569Phase 2

Paclitaxel/Carboplatin With or Without Cetuximab in CUP

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10